alan p. venook, md, on identifying subgroups of hcc patients that are likely to respond to therapy
Published 7 years ago • 38 plays • Length 0:52
Download video MP4
Download video MP3
Similar videos
-
1:18
alan venook, md, on the latest in identifying valid biomarkers in the treatment of hcc
-
5:39
hcc: criteria for resection and adjuvant therapy
-
1:54
alan p. venook, md, on integrating immunotherapy into existing treatment regimens for hcc patients
-
1:42
dr. alan p. venook on determining frontline treatment for mcrc
-
1:54
alan venook, md, explains how tumor sidedness affects therapeutic choice
-
48:15
hepatitis with dr. michael wellner
-
12:34
everything about liver cancer - learn about its diagnosis and treatment
-
7:17
proton therapy: liver cancer
-
6:54
diagnostic workup for hcc
-
1:30
alan venook, md, discusses vemurafenib and the nccn guidelines for mcrc patients
-
28:11
hepatocellular carcinoma - molecular approaches to treatment
-
1:05
alan p. venook, md, on integrating immunotherapy into treatment regimens for gastric cancer patients
-
1:47
alan venook, md discusses development of immunotherapies for non msi-high crc patients
-
2:03
alan venook, md, explains the biological difference between left-sided and right-sided crc tumors
-
9:11
transitioning to systemic therapy in hcc
-
33:28
assessing response after hepatic interventional oncology
-
1:17
alan p. venook, md, discusses which molecular tests to order for a newly diagnosed crc patient
-
1:00
venook: what are the principal options to control metastatic disease ?
-
1:37
alan p. venook, md, on integrating immunotherapy into existing treatment regimens for crc patients
-
1:53
dr. do on the assessment of tumor response in liver cancer
-
33:20
37. hepatocellular carcinoma: li-rads treatment response after locoregional therapy - part 2 (q&a)
-
4:53
checkpoint inhibition in hepatocellular carcinoma
Clip.africa.com - Privacy-policy